Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease
- PMID: 17569118
- PMCID: PMC4395634
- DOI: 10.3748/wjg.v13.i20.2826
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease
Abstract
Aim: To compare the anti-inflammatory properties of butyrate with two other SCFAs, namely acetate and propionate, which have less well-documented effects on inflammation.
Methods: The effect of SCFAs on cytokine release from human neutrophils was studied with ELISA. SCFA-dependent modulation of NF-kappaB reporter activity was assessed in the human colon adenocarcinoma cell line, Colo320DM. Finally, the effect of SCFAs on gene expression and cytokine release, measured with RT-PCR and ELISA, respectively, was studied in mouse colon organ cultures established from colitic mice.
Results: Acetate, propionate and butyrate at 30 mmol/L decreased LPS-stimulated TNFalpha release from neutrophils, without affecting IL-8 protein release. All SCFAs dose dependently inhibited NF-kappaB reporter activity in Colo320DM cells. Propionate dose-dependently suppressed IL-6 mRNA and protein release from colon organ cultures and comparative studies revealed that propionate and butyrate at 30 mmol/L caused a strong inhibition of immune-related gene expression, whereas acetate was less effective. A similar inhibition was achieved with the proteasome inhibitor MG-132, but not the p38 MAPK inhibitor SB203580. All SCFAs decreased IL-6 protein release from organ cultures.
Conclusion: In the present study propionate and butyrate were equipotent, whereas acetate was less effective, at suppressing NF-kappaB reporter activity, immune-related gene expression and cytokine release in vitro. Our findings suggest that propionate and acetate, in addition to butyrate, could be useful in the treatment of inflammatory disorders, including IBD.
Figures
Similar articles
-
The Inflammation Induced by Lipopolysaccharide can be Mitigated by Short-chain Fatty Acid, Butyrate, through Upregulation of IL-10 in Septic Shock.Scand J Immunol. 2017 Apr;85(4):258-263. doi: 10.1111/sji.12515. Scand J Immunol. 2017. PMID: 27943364
-
IL-33 Is Involved in the Anti-Inflammatory Effects of Butyrate and Propionate on TNFα-Activated Endothelial Cells.Int J Mol Sci. 2021 Feb 28;22(5):2447. doi: 10.3390/ijms22052447. Int J Mol Sci. 2021. PMID: 33671042 Free PMC article.
-
Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.Nutr Res. 2020 Nov;83:63-72. doi: 10.1016/j.nutres.2020.08.009. Epub 2020 Aug 22. Nutr Res. 2020. PMID: 33017771
-
Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.Adv Exp Med Biol. 1999;472:149-58. doi: 10.1007/978-1-4757-3230-6_13. Adv Exp Med Biol. 1999. PMID: 10736623 Review.
-
Short chain fatty acids, a possible treatment option for autoimmune diseases.Biomed Pharmacother. 2023 Jul;163:114763. doi: 10.1016/j.biopha.2023.114763. Epub 2023 Apr 25. Biomed Pharmacother. 2023. PMID: 37105078 Review.
Cited by
-
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.J Diabetes Res. 2016;2016:6014631. doi: 10.1155/2016/6014631. Epub 2015 Dec 29. J Diabetes Res. 2016. PMID: 27057552 Free PMC article.
-
Mucosal Immune Development in Early Life: Setting the Stage.Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):251-68. doi: 10.1007/s00005-015-0329-y. Epub 2015 Feb 11. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25666708 Free PMC article. Review.
-
Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study.Front Cell Infect Microbiol. 2022 Nov 21;12:1030588. doi: 10.3389/fcimb.2022.1030588. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36478672 Free PMC article.
-
Species-level characterization of the core microbiome in healthy dogs using full-length 16S rRNA gene sequencing.Front Vet Sci. 2024 Sep 2;11:1405470. doi: 10.3389/fvets.2024.1405470. eCollection 2024. Front Vet Sci. 2024. PMID: 39286595 Free PMC article.
-
Obesity and Its Multiple Clinical Implications between Inflammatory States and Gut Microbiotic Alterations.Diseases. 2022 Dec 29;11(1):7. doi: 10.3390/diseases11010007. Diseases. 2022. PMID: 36648872 Free PMC article. Review.
References
-
- Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12 Suppl 1:S3–S9. - PubMed
-
- Brynskov J, Nielsen OH, Ahnfelt-Rønne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis. 1994;12:290–304. - PubMed
-
- Fuss IJ. Cytokine network in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy. 2003;2:101–112. - PubMed
-
- Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol. 2002;168:5342–5351. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources